5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)-Reference-Cited by-同舟云学术

5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)

Published:2022-12 Issue:12 Volume:23 Page:1508-1516
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Siva Shankar,Ali Muhammad,Correa Rohann J M,Muacevic Alexander,Ponsky Lee,Ellis Rodney J,Lo Simon S,Onishi Hiroshi,Swaminath Anand,McLaughlin Mark,Morgan Scott C,Cury Fabio L,Teh Bin S,Mahadevan Anand,Kaplan Irving D,Chu William,Grubb William,Hannan Raquibul,Staehler Michael,Warner Andrew,Louie Alexander V

Funder

Cancer Council Tasmania

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Epidemiology of renal cell carcinoma;Capitanio;Eur Urol,2019

2. European Association of Urology guidelines on renal cell carcinoma: the 2022 update;Ljungberg;Eur Urol,2022

3. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2019

4. The multispeciality approach to the management of localised kidney cancer;Stewart;Lancet,2022

5. Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USA;Haque;Future Oncol,2018

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review;Future Oncology;2024-09-11

2. Renal Cell Carcinoma;JAMA;2024-08-28

3. Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer;BJU International;2024-08-26

4. Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-08

5. Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancer;Urologic Oncology: Seminars and Original Investigations;2024-08